EventsThe 5th International Electronic Conference on Applied Sciences
Published
This submission belongs to the session S1. Applied Biosciences and Bioengineering of the event The 5th International Electronic Conference on Applied Sciences
Published date
03 Dec, 2024
Academic Editor
author-avatarTakahito Ohshiro
Citation
CRISTIAN-CATALIN GAVAT, Newly Developed Quantitative Spectrophotometric Analysis in the Visible Range (VIS) of Lisinopril that belongs to angiotensin-converting enzyme inhibitors, in Proceedings of The 5th International Electronic Conference on Applied Sciences, 4 December–6 December 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Newly Developed Quantitative Spectrophotometric Analysis in the Visible Range (VIS) of Lisinopril that belongs to angiotensin-converting enzyme inhibitors

image
1. GRIGORE T. POPA University of Medicine and Pharmacy, Faculty of Medical Bioengineering, Biomedical Sciences Department, 16 Universitatii Street, Iasi 700115, Romania., Romania
Abstract

Lisinopril is a dipeptide containing an L-Proline group and an L-Lysine residue. It is an antiarrhythmic medication belonging to the family of angiotensin-converting enzyme (ACE) inhibitors . It effectively treats arterial hypertension (first-line treatment), heart failure, and heart attacks; it also prevents kidney problems in people with diabetes mellitus. The main purpose of this work consisted of the dosage of Lisinopril as a single active substance from pharmaceutical tablets. A new method for the quantitative analysis of Lisinopril using visible spectrophotometry (VIS) was found, optimized, and applied in laboratory practice. This method was based on the diazotization of the free primary amino group -NH2 of Lisinopril in cold conditions for 25 minutes at 1-5 degrees Celsius, in the presence of sodium nitrite 5 % and hydrochloric acid 10%-15%, followed by the quantitative coupling of the obtained diazonium salt with alpha-naphthol from an alkalized 0.2 % alcoholic solution. An intense orange azo dye with a reddish shade was dosed at the wavelength corresponding to the absorption maximum, λ = 489 nm, in relation to double-distilled water, which was used as a blank. The amount of pure Lisinopril found per tablet was 19.60 mg / coated tablet .This value was very close to the official reference value of 20 mg pure Lisinopril/tablet. The average percentage deviation was only 2.00% compared to the officially declared content of the active substance; this fell perfectly within the normal limits of the average percentage deviation allowed by the Romanian Pharmacopoeias 10th Edition and European Pharmacopoeias (± 7.5%). The method proposed to be applied for the visible spectrophotometric analysis of Lisinopril from pharmaceutical tablets presented a very good linearity over the entire chosen concentration range of 0.41 μg/mL - 12.24 μg/mL. The linear regression coefficient was R2 = 0.999085, which fit perfectly within the normal range of values, R2 ≥ 0.9990. The proposed method was then statistically validated.

Keywords
Lisinopril
antiarrhythmic medication
single active substance
main purpose
pharmaceutical tablet
chosen concentration range
Visible spectrophotometric analysis
average percentage deviation
normal range of values.
In Silico Electrophysiological Analysis Highlights Cardiac Toxicity of Ibrutinib in B-Cell Lymphoma Therapy through Sodium Current Inhibition
Applicability assessment of a proteolytic fermentation broth to leather tanning and protein stain removal